These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11809124)

  • 1. The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review.
    Stewart A; Sandercock J; Bryan S; Hyde C; Barton PM; Fry-Smith A; Burls A
    Health Technol Assess; 2001; 5(2):1-97. PubMed ID: 11809124
    [No Abstract]   [Full Text] [Related]  

  • 2. Riluzole for motor neurone disease. Large, more economical trial is needed.
    Wheatley K; Gray R
    BMJ; 2001 May; 322(7297):1305. PubMed ID: 11403061
    [No Abstract]   [Full Text] [Related]  

  • 3. Riluzole for motor neurone disease. More trials are needed.
    Sandercock J; Burls A; Hyde C; Fry-Smith A; Barton P; Bryan S; Stewart A
    BMJ; 2001 May; 322(7297):1305. PubMed ID: 11403060
    [No Abstract]   [Full Text] [Related]  

  • 4. Rilutek now subsidised.
    Smith W
    Nurs N Z; 2013 Nov; 19(10):4. PubMed ID: 24427977
    [No Abstract]   [Full Text] [Related]  

  • 5. Riluzole for motor neurone disease. Reply from chairman of appraisal committee at NICE.
    Barnett D
    BMJ; 2001 Sep; 323(7312):573. PubMed ID: 11573490
    [No Abstract]   [Full Text] [Related]  

  • 6. Riluzole: a glimmer of hope in the treatment of motor neurone disease.
    Kiernan MC
    Med J Aust; 2005 Apr; 182(7):319-20. PubMed ID: 15804220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preface: the state of the science of all motor neuron diseases.
    Weiss MD; Carter GT
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):xix-xx. PubMed ID: 18625405
    [No Abstract]   [Full Text] [Related]  

  • 8. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Easier access to motor neurone drug.
    Smith W
    Nurs N Z; 2004 Oct; 10(9):5. PubMed ID: 19777649
    [No Abstract]   [Full Text] [Related]  

  • 10. The cost utility analysis of riluzole for the treatment of amyotrophic lateral sclerosis in the UK.
    Tavakoli M; Malek M
    J Neurol Sci; 2001 Oct; 191(1-2):95-102. PubMed ID: 11676998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidisciplinary management of motor neurone disease.
    Lau FS; Brennan FP; Gardiner MD
    Aust J Gen Pract; 2018 Sep; 47(9):593-597. PubMed ID: 30244551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riluzole: a glimmer of hope in the treatment of motor neurone disease.
    Henderson RD; McCombe PA
    Med J Aust; 2005 Aug; 183(3):164; author reply 164-5. PubMed ID: 16053424
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness associated with amyotrophic lateral sclerosis: some questions and answers pending.
    Fiorentino G; Esquinas AM
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):315-316. PubMed ID: 29191046
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors influencing a patient's decision regarding riluzole: an early experience.
    Rudnicki SA
    J Neurol Sci; 1997 Oct; 152 Suppl 1():S80-1. PubMed ID: 9419060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to palliative care for people with motor neurone disease in New Zealand: a patient's perspective.
    Williams B
    N Z Med J; 2005 Oct; 118(1224):U1711. PubMed ID: 16258583
    [No Abstract]   [Full Text] [Related]  

  • 16. Rilutek should be subsidised.
    Smith W
    Nurs N Z; 2005 Oct; 11(9):4. PubMed ID: 16529266
    [No Abstract]   [Full Text] [Related]  

  • 17. Riluzole therapy for motor neurone disease: an early Australian experience (1996-2002).
    Zoing MC; Burke D; Pamphlett R; Kiernan MC
    J Clin Neurosci; 2006 Jan; 13(1):78-83. PubMed ID: 16410201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Studies in Motor Neurone Disease: A Systematic Methodological Review.
    Moore A; Young CA; Hughes DA
    Pharmacoeconomics; 2017 Apr; 35(4):397-413. PubMed ID: 27975196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness: summary.
    Ringel SP
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S67-9. PubMed ID: 12396813
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of motor neurone disease.
    Turner M
    Practitioner; 2001 Jun; 245(1623):530-2, 536-8. PubMed ID: 11436263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.